Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho-Sup Lee

Showing results (111-120 of 137) with videos related to

Pageof 14
Sort By:
American Journal of Hematology|August 24, 2017
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapyHyungwoo Cho, Dok Hyun Yoon, Jung Bok Lee, et al.
Annals of Hematology|January 15, 2021
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trialJi Hyun Lee, Yong Park, Ka-Won Kang, et al.
Blood Research|August 13, 2025
A comprehensive analysis of the role of stem cell transplantation in mantle cell lymphoma: real-world data from the Korean Society of Blood and Marrow Transplantation registry: Stem cell transplantation outcomes in mantle cell lymphomaDong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
Cancer Communications (London, England)|October 18, 2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
International Journal of Hematology|October 16, 2012
Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)Sung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Leukemia & Lymphoma|June 26, 2020
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysisGa-Young Song, Sung-Hoon Jung, Je-Jung Lee, et al.
British Journal of Haematology|March 11, 2025
Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasmJi Hyun Lee, Sung-Yong Oh, Taek Gyu Lee, et al.
Haematologica|July 3, 2025
Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemiaJae-Sook Ahn, Joo Heon Park, ChangSun Lee, et al.
Cancer Science|September 14, 2010
Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Pageof 14

Showing results (111-120 of 137) with videos related to

Sort By:
Pageof 14
American Journal of Hematology|August 24, 2017
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapyHyungwoo Cho, Dok Hyun Yoon, Jung Bok Lee, et al.
Annals of Hematology|January 15, 2021
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trialJi Hyun Lee, Yong Park, Ka-Won Kang, et al.
Blood Research|August 13, 2025
A comprehensive analysis of the role of stem cell transplantation in mantle cell lymphoma: real-world data from the Korean Society of Blood and Marrow Transplantation registry: Stem cell transplantation outcomes in mantle cell lymphomaDong Won Baek, Joon Ho Moon, Jae Hoon Lee, et al.
Cancer Communications (London, England)|October 18, 2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
International Journal of Hematology|October 16, 2012
Waldeyer's ring marginal zone B cell lymphoma: are the clinical and prognostic features nodal or extranodal? A study by the Consortium for Improving Survival of Lymphoma (CISL)Sung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Leukemia & Lymphoma|June 26, 2020
Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysisGa-Young Song, Sung-Hoon Jung, Je-Jung Lee, et al.
British Journal of Haematology|March 11, 2025
Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasmJi Hyun Lee, Sung-Yong Oh, Taek Gyu Lee, et al.
Haematologica|July 3, 2025
Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemiaJae-Sook Ahn, Joo Heon Park, ChangSun Lee, et al.
Cancer Science|September 14, 2010
Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Blood Cancer Journal|December 2, 2021
Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and <sup>18</sup>F-FDG PET/CTHee Jeong Cho, Sung-Hoon Jung, Jae-Cheol Jo, et al.
Pageof 14